Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  St. Jude Medical, Inc.    

SummaryNewsCompany 
News SummaryMost relevantAll newsSector newsTweets

St. Jude Medical, Inc. : ITG Investment Research Launches New Apple iTV Report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/03/2012 | 02:05pm CEST

NEW YORK, April 3, 2012 /PRNewswire/ -- ITG (NYSE: ITG), a leading agency research broker and financial technology firm, today announced the launch of a new thematic report on the Apple iTV product opportunity and the potential implications for Apple's (NASDAQ: AAPL) revenue growth.

(Logo: http://photos.prnewswire.com/prnh/20120123/NY39237LOGO )

The Apple iTV report, available to clients of the ITG Investment Research consumer technology vertical, quantifies the potential market opportunity for iTV, using data-driven analysis to provide 8 distinct scenarios. An interactive model is also available, which allows investors to apply their own assumptions about iTV growth and profitability.

The Apple iTV report was produced by new ITG Investment Research analyst Joe Fersedi and ITG IR CEO Tony Berkman. Mr. Fersedi will be collaborating with Mr. Berkman on coverage of the consumer technology sector. Prior to joining ITG, Fersedi worked as a consumer analyst at AllianceBernstein and a media, cable and satellite analyst at Bank of America.

"Joe's broad-based research background combined with our unique methodology will allow us to provide even more valuable consumer technology insights to our clients," said Berkman. "This new iTV report is the latest example of how we can deliver thematic, data-driven insights which clients cannot get from other research providers on the Street."

ITG Investment Research provides coverage of over 300 companies in more than 20 sectors, including recent research initiations on St. Jude Medical (NYSE: STJ), McDonald's (NYSE: MCD) and Dunkin' Brands (NASDAQ: DNKN). ITG IR also provides macro energy and economic research and bespoke research projects. For more on ITG's research capabilities, visit www.itginvestmentresearch.com.

About ITG

ITG is an independent research and execution broker that partners with global portfolio managers and traders to provide unique data-driven insights throughout the investment process. From investment decision through settlement, ITG helps clients understand market trends, improve performance, mitigate risk and navigate increasingly complex markets. ITG is headquartered in New York with offices in North America, Europe, and Asia Pacific. For more information, please visit www.itg.com.

Media/Investor Contact:

J.T. Farley
(212) 444-6259
corpcomm@itg.com

SOURCE ITG

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ST. JUDE MEDICAL, INC.
06/01 ST JUDE MEDICAL : Patent Issued for Surgical Heart Valve Flexible Stent Frame St..
06/01 ST JUDE MEDICAL : "Leaflet-Cuff Attachments for Prosthetic Heart Valve" in Paten..
05/25 ST JUDE MEDICAL : Patent Issued for Catheter with Atraumatic Tip (USPTO 9649155)
05/25 ST JUDE MEDICAL : An Application for the Trademark "COOL PATH" Has Been Filed by..
05/18 ST JUDE MEDICAL : Patent Issued for System for Loading a Collapsible Heart Valve..
05/18 ST JUDE MEDICAL : Studies from St. Jude Medical, Inc. in the Area of Cardiology ..
05/18 ST JUDE MEDICAL : Patent Issued for Apparatus and Method for Heart Valve Repair ..
05/18 ST JUDE MEDICAL : Patent Issued for Medical Catheter with Deflection Pull Ring a..
05/11 ST JUDE MEDICAL : "Alignment of an Implantable Medical Device" in Patent Applica..
05/11 ST JUDE MEDICAL : Class-action lawsuit initiated over potentially defective card..
More news
News from SeekingAlpha
04/27 DIVIDEND STREAKS IN DANGER : 2016 Review And 2017 Preview
04/18 Abbott-Alere Deal To Go Ahead
02/17 GLAZER CAPITAL : Merger Arbitrage With Convertibles - A Lower Risk Alternative
02/15 Panel To Stand Sentinel Over Embolic Filter
02/01 Dividend Champions For February 2017